Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
SUPREFACT DEPOT 3 MONTHS | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 9.45MG | Updated Report | 2024-05-16 | 207981 |
ANANDRON | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 50MG | Updated Report | 2024-05-16 | 204346 |
FLOLAN | GLAXOSMITHKLINE INC | Actual shortage | 1.5MG | Updated Report | 2024-05-16 | 220338 |
VIIBRYD | ABBVIE CORPORATION | Anticipated shortage | 20MG | New Report | 2024-05-16 | 228152 |
TEVA-CYCLOSPORINE | TEVA CANADA LIMITED | Actual shortage | 0.05% | New Report | 2024-05-16 | 228149 |
RATIO-TOPISALIC | TEVA CANADA LIMITED | Actual shortage | 20MG 0.5MG | New Report | 2024-05-16 | 228146 |
ACT METHYLPHENIDATE ER | TEVA CANADA LIMITED | Actual shortage | 54MG | New Report | 2024-05-16 | 228143 |
TEVA-NAPROXEN | TEVA CANADA LIMITED | Actual shortage | 500MG | New Report | 2024-05-16 | 228140 |
TEVA-DOMPERIDONE | TEVA CANADA LIMITED | Resolved | 10MG | Updated Report | 2024-05-16 | 220980 |
ACT CLARITHROMYCIN XL | TEVA CANADA LIMITED | Resolved | 500MG | Updated Report | 2024-05-16 | 215737 |
TEVA-BUPROPION XL | TEVA CANADA LIMITED | Resolved | 150MG | Updated Report | 2024-05-16 | 225492 |
FENTORA | TEVA CANADA LIMITED | Resolved | 800MCG | Updated Report | 2024-05-16 | 227506 |
TEVA-CARVEDILOL | TEVA CANADA LIMITED | Actual shortage | 3.125MG | Updated Report | 2024-05-16 | 227471 |
TEVA-CARVEDILOL | TEVA CANADA LIMITED | Actual shortage | 6.25MG | Updated Report | 2024-05-16 | 227474 |
TEVA-MOMETASONE | TEVA CANADA LIMITED | Actual shortage | 0.1% | Updated Report | 2024-05-16 | 220986 |
TEVA-COMBO STERINEBS | TEVA CANADA LIMITED | Actual shortage | 0.5MG 2.5MG | Updated Report | 2024-05-16 | 226939 |
TEVA-BUDESONIDE | TEVA CANADA LIMITED | Actual shortage | 0.5MG | Updated Report | 2024-05-16 | 195478 |
TEVA-TECNAL | TEVA CANADA LIMITED | Actual shortage | 330MG 40MG 50MG | Updated Report | 2024-05-16 | 224448 |
TEVA-SIMVASTATIN | TEVA CANADA LIMITED | Actual shortage | 40MG | Updated Report | 2024-05-16 | 215722 |
TEVA-EZETIMIBE | TEVA CANADA LIMITED | Actual shortage | 10MG | Updated Report | 2024-05-16 | 223850 |
TEVA-CANDESARTAN | TEVA CANADA LIMITED | Actual shortage | 16MG | Updated Report | 2024-05-16 | 220267 |
TEVA-SUCRALFATE | TEVA CANADA LIMITED | Actual shortage | 1G | Updated Report | 2024-05-16 | 213368 |
TEVA-BUPRENORPHINE/NALOXONE | TEVA CANADA LIMITED | Actual shortage | 2MG 8MG | Updated Report | 2024-05-16 | 221537 |
TEVA-NITROFURANTOIN | TEVA CANADA LIMITED | Actual shortage | 100MG | Updated Report | 2024-05-16 | 219677 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | TEVA CANADA LIMITED | Actual shortage | 10MG | Updated Report | 2024-05-16 | 166969 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | TEVA CANADA LIMITED | Actual shortage | 20MG | Updated Report | 2024-05-16 | 166972 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | TEVA CANADA LIMITED | Actual shortage | 30MG | Updated Report | 2024-05-16 | 166975 |
DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP | BAXTER CORPORATION | Actual shortage | 50MG 1.6MG | New Report | 2024-05-16 | 228098 |
REMERON RD | ORGANON CANADA INC. | Anticipated shortage | 15MG | Updated Report | 2024-05-16 | 227146 |
NASONEX | ORGANON CANADA INC. | Actual shortage | 50MCG | Updated Report | 2024-05-16 | 224304 |
COSOPT PRESERVATIVE-FREE | ELVIUM LIFE SCIENCES | Actual shortage | 5MG 20MG | Updated Report | 2024-05-16 | 227864 |
SOLU-CORTEF | PFIZER CANADA ULC | Actual shortage | 250MG | Updated Report | 2024-05-16 | 225355 |
!!T3 BUPIVACAINE INJECTION BP | STERIMAX INC | Actual shortage | 2.5MG | Updated Report | 2024-05-16 | 213678 |
!!T3 BUPIVACAINE INJECTION BP | STERIMAX INC | Actual shortage | 2.5MG | Updated Report | 2024-05-16 | 213681 |
M-ESCITALOPRAM | MANTRA PHARMA INC | Resolved | 20MG | Updated Report | 2024-05-16 | 225521 |
M-ESCITALOPRAM | MANTRA PHARMA INC | Resolved | 10MG | Updated Report | 2024-05-16 | 225515 |
SERTRALINE | SANIS HEALTH INC | Actual shortage | 50MG | Updated Report | 2024-05-16 | 217783 |
SERTRALINE | SANIS HEALTH INC | Actual shortage | 100MG | Updated Report | 2024-05-16 | 216254 |
SERTRALINE | SANIS HEALTH INC | Actual shortage | 25MG | Updated Report | 2024-05-16 | 216264 |
M-ESCITALOPRAM | MANTRA PHARMA INC | Resolved | 10MG | Updated Report | 2024-05-16 | 225518 |
VENLAFAXINE XR | SANIS HEALTH INC | Actual shortage | 37.5MG | Updated Report | 2024-05-16 | 225878 |
RISPERIDONE | SANIS HEALTH INC | Actual shortage | 0.25MG | Updated Report | 2024-05-16 | 223270 |
GABAPENTIN | SANIS HEALTH INC | Actual shortage | 400MG | Updated Report | 2024-05-16 | 223259 |
FLUOXETINE | SANIS HEALTH INC | Actual shortage | 20MG | Updated Report | 2024-05-16 | 164466 |
FLUOXETINE | SANIS HEALTH INC | Actual shortage | 20MG | Updated Report | 2024-05-16 | 164462 |
OCUFLOX | ABBVIE CORPORATION | Actual shortage | 0.3% | Updated Report | 2024-05-16 | 217532 |
ALFUZOSIN | SANIS HEALTH INC | Actual shortage | 10MG | Updated Report | 2024-05-16 | 223485 |
FLUOXETINE | SANIS HEALTH INC | Actual shortage | 10MG | Updated Report | 2024-05-16 | 164459 |
SOLU-MEDROL | PFIZER CANADA ULC | Actual shortage | 1G | Updated Report | 2024-05-16 | 220618 |
PROZAC CAPSULES 10MG | ELI LILLY CANADA INC | Actual shortage | 10MG | Updated Report | 2024-05-16 | 220045 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
SUPREFACT DEPOT 2 MONTHS | CHEPLAPHARM ARZNEIMITTEL GMBH | To be discontinued | 6.3MG | New Report | 2024-05-16 | 228169 |
SUPREFACT DEPOT 3 MONTHS | CHEPLAPHARM ARZNEIMITTEL GMBH | To be discontinued | 9.45MG | New Report | 2024-05-16 | 228166 |
ANANDRON | CHEPLAPHARM ARZNEIMITTEL GMBH | To be discontinued | 50MG | Updated Report | 2024-05-16 | 228155 |
EYE STREAM | ALCON CANADA INC | Discontinued | 0.03% 0.048% 0.075% 0.64% | New Report | 2024-05-15 | 228021 |
MYLAN-NITRO SUBLINGUAL SPRAY | MYLAN PHARMACEUTICALS ULC | Discontinued | 0.4MG | New Report | 2024-05-08 | 227338 |